The case against universal WBC reduction (and for the practice of evidence-based medicine)

被引：25

作者：

Goodnough, LT

机构：

[1] Washington Univ, Barnes Jewish Hosp, Sch Med, Dept Med & Pathol, St Louis, MO USA

[2] Washington Univ, Barnes Jewish Hosp, Sch Med, Dept Immunol, St Louis, MO USA

来源：

TRANSFUSION | 2000年 / 40卷 / 12期

关键词：

D O I：

10.1046/j.1537-2995.2000.40121522.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1522 / 1527

页数：6

共 52 条

[31]

McAlister FA, 1998, BRIT J SURG, V85, P171

[32]

McFarland J, 1997, NEW ENGL J MED, V337, P1861

[33] FEBRILE TRANSFUSION REACTION - WHAT BLOOD COMPONENT SHOULD BE GIVEN NEXT [J].

MENITOVE, JE ;

MCELLIGOTT, MC ;

ASTER, RH .

VOX SANGUINIS, 1982, 42 (06) :318-321

[34]

MOWBRAY JF, 1985, LANCET, V1, P941

[35] USE OF LEUKOCYTE-POOR BLOOD COMPONENTS AND HLA-MATCHED-PLATELET DONORS TO PREVENT HLA ALLOIMMUNIZATION [J].

MURPHY, MF ;

METCALFE, P ;

THOMAS, H ;

EVE, J ;

ORD, J ;

LISTER, TA ;

WATERS, AH .

BRITISH JOURNAL OF HAEMATOLOGY, 1986, 62 (03) :529-534

[36]

Napier A, 1998, TRANSFUSION MED, V8, P59

[37] Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial [J].

Ober, C ;

Karrison, T ;

Odem, RR ;

Barnes, RB ;

Branch, DW ;

Stephenson, MD ;

Baron, B ;

Walker, MA ;

Scott, JR ;

Schreiber, JR .

LANCET, 1999, 354 (9176) :365-369

[38] PREVENTION OF ALLOIMMUNIZATION IN PATIENTS WITH ACUTE-LEUKEMIA BY USE OF WHITE CELL-REDUCED BLOOD COMPONENTS - A RANDOMIZED TRIAL [J].

OKSANEN, K ;

KEKOMAKI, R ;

RUUTU, T ;

KOSKIMIES, S ;

MYLLYLA, G .

TRANSFUSION, 1991, 31 (07) :588-594

[39] IMPROVEMENT OF KIDNEY-GRAFT SURVIVAL WITH INCREASED NUMBERS OF BLOOD TRANSFUSIONS [J].

OPELZ, G ;

TERASAKI, PI .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (15) :799-803

[40]

SCHIFFER CA, 1983, BLOOD, V62, P815

← 1 2 3 4 5 6 →